Copley Scientific is pleased to be returning to the Drug Delivery to the Lungs (DDL) Conference, taking place in Edinburgh, UK, from 9–11 December 2026, and once again supporting the event as Platinum Sponsors.
Bringing together scientists, academics, clinicians, regulators and industry experts from across the global inhalation community, DDL provides an important forum for sharing the latest research and developments in pulmonary and nasal drug delivery. Across three days of scientific lectures, poster presentations, industry exhibitions and networking, the conference offers an opportunity to exchange knowledge and explore the challenges and innovations shaping the future of inhaled medicines.
Our team will be available throughout DDL 2026 to connect with delegates, share expertise and discuss the latest innovations in inhaled and nasal drug product testing.
Whether you have a specific testing challenge or would simply like to explore what’s new from Copley, visit us at the exhibition or contact us in advance at sales@copleyscientific.co.uk to arrange a meeting.
We look forward to seeing you there.
